Public Health England
New data show vaccines reduce severe COVID-19 in older adults
New data show both Pfizer-BioNTech and Oxford-AstraZeneca vaccines significantly reduce severe COVID-19 in older adults.
Public Health England (PHE) yesterday submitted a pre-print of a real-world study that shows that both the Pfizer and Oxford-AstraZeneca vaccines are highly effective in reducing COVID-19 infections among older people aged 70 years and over. Since January, protection against symptomatic COVID, 4 weeks after the first dose, ranged between 57 and 61% for one dose of Pfizer and between 60 and 73% for the Oxford-AstraZeneca vaccine.
The pre-print article:
- compares the rate of vaccination in symptomatic people aged over 70 years of age who test positive for COVID-19, compared to those who test negative
- compares the rate of hospitalisation in confirmed COVID-19 cases aged over 80 who were vaccinated more than 14 days before testing positive, compared to unvaccinated cases
- compares the rate of deaths in confirmed COVID-19 cases aged over 80 who were vaccinated with Pfizer vaccine more than 14 days before testing positive, compared to unvaccinated cases
In the over 80s, data suggest that a single dose of either vaccine is more than 80% effective at preventing hospitalisation, around 3 to 4 weeks after the jab. There is also evidence for the Pfizer vaccine, which suggests it leads to an 83% reduction in deaths from COVID-19.
The data also shows symptomatic infections in over 70s decreasing from around 3 weeks after one dose of both vaccines.
The new analysis adds to growing evidence that the vaccines are working and are highly effective in protecting people against severe illness, hospitalisation and death.
Dr Mary Ramsay, PHE Head of Immunisation, yesterday said:
“This adds to growing evidence showing that the vaccines are working to reduce infections and save lives.
“While there remains much more data to follow, this is encouraging and we are increasingly confident that vaccines are making a real difference.
“It is important to remember that protection is not complete and we don’t yet know how much these vaccines will reduce the risk of you passing COVID-19 onto others.
“Even if you have been vaccinated, it is it is really important that you continue to act like you have the virus, practise good hand hygiene and stay at home.”
From this week, the NHS has started to deliver second doses to those people vaccinated first, which will provide higher and longer lasting protection.
Separate studies in healthcare workers show that one dose of the vaccine is preventing people from catching asymptomatic COVID-19 by at least 70%. This will help to reduce the spread of infection in hospitals and care homes, ultimately offering more protection to these vulnerable populations.
Latest News from
Public Health England
Weekly national flu and COVID-19 surveillance reports published16/04/2021 12:05:00
National influenza and COVID-19 report, monitoring coronavirus (COVID-19) activity, seasonal flu and other seasonal respiratory illnesses.
COVID-19 vaccines have prevented 10,400 deaths in older adults12/04/2021 10:10:10
PHE analysis suggests the UK COVID-19 vaccination programme has so far prevented thousands of deaths in those aged 60 and above.
New JCVI advice on use of the AstraZeneca COVID-19 vaccine08/04/2021 14:05:00
The JCVI has issued new advice regarding the AstraZeneca COVID-19 vaccine after reports of extremely rare blood clots.
Dr Jenny Harries marks official launch of UK Health Security Agency06/04/2021 11:10:00
New chief executive marked her first day with a visit to Colindale laboratories in North London, accompanied by Health Secretary Matt Hancock.
New vaccine advice for adults living with adults who are immunosuppressed30/03/2021 09:05:00
JCVI recommends that adults living with adults who are immunosuppressed should be prioritised for the COVID-19 vaccine.
COVID-19 vaccines have prevented thousands of deaths in older adults, new data shows26/03/2021 09:33:00
Analysis carried out by Public Health England suggests that the COVID-19 vaccination programme prevented 6,100 deaths in England up to the end of February 2021.
PHE study shows three-quarters of over 70s have COVID-19 antibodies18/03/2021 16:38:00
New findings from Public Health England have shown that an estimated 75.8% of 70 to 84 year old blood donors had antibodies against COVID-19 by early March.
JCVI advises prioritising homeless people and rough sleepers for COVID-19 vaccine12/03/2021 16:10:00
The JCVI has advised the government to prioritise people experiencing homelessness, including those sleeping rough, for the coronavirus (COVID-19) vaccine.